In recent years, the diagnostic work‐up for prostate cancer (PCa) has emerged to incorporate the routine use of multiparametric magnetic resonance imaging (mpMRI) in men with an elevated prostate specific antigen (PSA) level.1 The gene discussed is KLK3; the disease is prostate carcinoma.